Podcast Episodes
Back to SearchArtificial Sweetener May Impair Cancer Immunotherapy, Raising Broader Questions
Episode 16
The artificial sweetener sucralose may impair the efficacy of cancer immunotherapy, according to a recent study published in Science. Although further research is needed before these findings can be …
Published on 3 hours ago
“Massive Advance” Changes the Chessboard in EGFR-Mutated Metastatic NSCLC
Episode 15
New survival data from the FLAURA2 and MARIPOSA trials represent “a massive advance for our patients” in terms of frontline treatment for EGFR-mutated non-small cell lung cancer says Sandip P. Patel,…
Published on 6 days ago
Are Oral SERDs About to Transform Breast Cancer Care?
Episode 14
The development of oral selective estrogen receptor degraders (SERDs) represents substantial progress for patients with metastatic breast cancer who have ESR1 mutations. “I’m extremely excited becaus…
Published on 2 months, 1 week ago
Game-Changers and Paradigm Shifts: ASCO 2025 Data Shake Up Breast Cancer Care
Episode 12
From a “game-changer” in triple-negative disease to broader paradigm shifts and practice changes, the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting was pivotal for breast cancer ca…
Published on 2 months, 1 week ago
Practice-Changing Data in Colorectal Cancer Lead to Broader Questions in Oncology
Episode 11
Results from the phase 3 ATOMIC trial are practice changing for colorectal cancer care and raise broader questions about immunotherapy use in patients with mismatch repair deficiencies across tumor t…
Published on 2 months, 1 week ago
Oncologist Faculty Burnout Caused by “Unrealistic” Expectations, Says ASCO CEO
Episode 13
“An increasingly unrealistic set of performance expectations” is putting a strain on oncologist faculty members, says Clifford Hudis, MD, CEO of the American Society of Clinical Oncology (ASCO). He d…
Published on 2 months, 2 weeks ago
After Years of Inactivity, “Dizzying” Changes Hit Bladder Cancer Care
Episode 10
“For the first 15 years of my career, we had nothing new” in bladder cancer care, said Jonathan E. Rosenberg, MD, chief of the genitourinary oncology service at Memorial Sloan Kettering Cancer Center…
Published on 2 months, 2 weeks ago
Practice Changing or “Practice Confounding”? Pivotal Breast Cancer Data Raise Big Questions
Episode 9
Findings from the SERENA-6 trial, which examined switching therapies in patients with breast cancer ahead of disease progression, made headlines during the 2025 American Society of Clinical Oncology …
Published on 2 months, 2 weeks ago
NCCN CEO Discusses Guideline Updates, Other Key Initiatives
Episode 8
From digitizing its guidelines to potential embedding them in EMRs, the National Comprehensive Cancer Network (NCCN) is working to “make the workflow easier and better” for oncologists, Crystal S. D…
Published on 2 months, 3 weeks ago
Former National Cancer Institute Director Discusses the Future of Cancer Care
Episode 5
“Is it time to do something big and different? That’s always a good question to ask,” said W. Kimryn Rathmell, MD, PhD, MMHC, the immediate former director of the National Cancer Institute (NCI) and …
Published on 2 months, 4 weeks ago